Image For Activity Cover
ORN Summer 2024 - Kratom Consumers in the United States: What clinicians need to know
AVAILABLE ON-DEMAND
Available on-demand. Login or create an account to register to view the recording.
Description:

Using recently collected data in the United States, this lecture will focus on kratom pharmacology and product types, use patterns and effects, consumer demographics and use motivations, and health impacts including physical dependence or use disorder.

Learning objectives:
At the conclusion of this seminar, attendees should be able to:
  1. Describe the different types of kratom products most often used in the US and understand their differences;
  2. Describe the basic pharmacology of kratom;
  3. Define the motivations for kratom use and acute effects from use;
  4. Define the current regulatory, legal, and research state of kratom;
  5. Evaluate and assess patients who use kratom more comprehensively, including evaluating the difference between physical dependence and substance use disorder.
Claim Credits & Course Materials

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):
  1. Complete the required course materials.
  2. Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.
What is ORN
Speaker:
Kirsten Elin Smith, Ph.D

Kirsten Elin Smith, Ph.D. is an Assistant Professor in the Behavioral Pharmacology Research Unit within the Department of Psychiatry and Behavioral Sciences in the Johns Hopkins University School of Medicine. After earning her Masters in Social Work from the University of Kentucky and Ph.D. from the University of Louisville, Dr. Smith completed a 4-year postdoctoral fellowship at the National Institute on Drug Abuse Intramural Research Program, working in the Translational Addiction Medicine Branch. Dr. Smith completed her NIDA K99-funded project that involved a national ecological momentary assessment of daily kratom use and a controlled drug administration substudy that investigated the acute effects of commercial kratom products. Her NIDA R00-funded study at Johns Hopkins University will further examine the pharmacokinetics/pharmacodynamics of kratom and will assess kratom withdrawal. Dr. Smith plans to continue her kratom research by next investigating the safety, tolerability, and human abuse potential of kratom in healthy adults using both standardized whole leaf formulations and isolated alkaloids.
DISCLAIMER

ACCREDITATION:
This actvity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association and The American Osteopathic Academy of Addiction Medicine (AOAAM). The American Osteopathic Association is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT HOURS:
The American Osteopathic Association designates this other activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION:
All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.

Funding:

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Summary
Availability: No future session
Expires on Aug 01, 2027
Cost: FREE
Credit Offered:
1 AMA PRA Category 1 Credit
1 AOA Category 1A Credit
Recommended
Powered By